IAGON

New to The Street Airs Five Corporate Interviews, Televised Episodes 562 and 563 as Sponsored Programming on Bloomberg TV and The FOX Business Network

Retrieved on: 
Friday, March 15, 2024
IAGON, NSO, Mining, Nutrient, PROMO, Bloomberg Television, FRA, Interview, Worldwide Angel, PEA, OTCQX, IP, Corporation, Be Water, Wood, NSO Group, Silver, Amazon, Misa, GPS, Multi, Gold, Privacy, OTCQB, Data management, Camping World, Whole Foods Market, Fox Business, Big Tech, MFB, Farm, LG, Data mining, Internet, Foot, Management, AI, Roger Hawkins (drummer), Walmart, Fire, Chicken, Movement, Hacking, OST, Immersion, Cattle, IAG, Pisgah National Forest, Health, Apple, Recycling, Blockchain, BLM, Meta, Government agency, CBD, Game, EPA, Water, Ecosystem, Host, Pegasus, Firefighter, NAV, Television presenter

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- New to The Street , an FMW Media business show production, will air its corporate interviews, episodes 562 and 563, as Sponsored Programming on Bloomberg TV and FOX Business Network .

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- New to The Street , an FMW Media business show production, will air its corporate interviews, episodes 562 and 563, as Sponsored Programming on Bloomberg TV and FOX Business Network .
  • Bloomberg TV airs Episode 562 as a sponsored programming Saturday, March 16, 2024, at 6:30 PM ET, featuring the following five (5) Corporate Guests:
    1).
  • FOX Business Network airs Episode 563 as a sponsored programming Monday, March 18, 2024, at 10:30 PM PT, featuring the following five (5) Corporate Guests:
    1).
  • The interview will air on the FOX Business Network, episode 563, on Monday, March 18, 2024, at 10:30 PM PT.

New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT

Retrieved on: 
Friday, January 5, 2024
IAGON, Dark, Mastercard, FDA, Multi, GOLD, Worldwide Angel, Lloyd's of London, Data mining, Machine learning, Interview, Web page, OTCQX, PROMO, Game Changer, Nursing, IAG, Host, Television presenter, Name, Privacy, IP, Silver, FBI, Ecosystem, FRA, Internet, OTCQB, Patient, Data management, Corporation, Theft, Gold, CDI, Hospital, European Medicines Agency, Constitution, Crime, Publication, MGM Resorts International, Cryptocurrency

As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.

Key Points: 
  • As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.
  • Based on positive data from Phase 2a and Phase 2b, management is now going forward with the FDA Phase 3.
  • The Company compared its top-line data with the currently used standard-of-care drugs in the marketplace, and Ibezapolstat has impressive positive results.
  • Phases 2a and 2b confirmed that the drug had success in 25 out of 26 patients, approximately 96% success with no reinfections.